Dana Hu-Lowe
Corporate Officer/Principal at ADAGENE INC.
Dana Hu-Lowe active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 2021-10-31 | - |
Career history of Dana Hu-Lowe
Former positions of Dana Hu-Lowe
| Companies | Position | Start | End |
|---|---|---|---|
| TURG POIN | Director/Board Member | 2019-03-31 | 2021-09-30 |
| Corporate Officer/Principal | 2019-03-31 | 2021-09-30 | |
| Wellspring Biosciences, Inc. | Corporate Officer/Principal | 2013-02-28 | 2019-02-28 |
Training of Dana Hu-Lowe
| University of Mississippi | Doctorate Degree |
| Beijing Normal University | Undergraduate Degree |
Statistics
International
| United States | 4 |
| China | 3 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ADAGENE INC. | Health Technology |
| Private companies | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
| Wellspring Biosciences, Inc. |
- Stock Market
- Insiders
- Dana Hu-Lowe
- Experience
